Showing results (111-120 of 276) with videos related to
Sort By:
Pageof 28
Journal of Cell Science|February 1, 1994
Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expressionJ P Molès, J T Schiller, A Tesniere, et al.Plos Pathogens|July 15, 2006
Carrageenan is a potent inhibitor of papillomavirus infectionChristopher B Buck, Cynthia D Thompson, Jeffrey N Roberts, et al.American Journal of Veterinary Research|August 11, 2001
Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horsesE A Carr, A P Théon, B R Madewell, et al.International Journal of Cancer|May 14, 1998
Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989V af Geijersstam, Z Wang, I Lewensohn-Fuchs, et al.Journal of Virology|May 1, 1996
Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibitionR B Roden, N L Hubbert, R Kirnbauer, et al.Journal of Clinical Microbiology|December 1, 1996
Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNAZ Wang, B G Hansson, O Forslund, et al.Plos Pathogens|April 27, 2012
Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosisMario Schelhaas, Bhavin Shah, Michael Holzer, et al.Journal of Virology|March 14, 2022
Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum ConditionsNathan R Fons, Rhonda C Kines, Cynthia D Thompson, et al.Vaccine|September 29, 2015
A cholesterol-lowering VLP vaccine that targets PCSK9Erin Crossey, Marcelo J A Amar, Maureen Sampson, et al.The Journal of General Virology|December 2, 1999
Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesisIlvars Silins, Zhaohui Wang, Elisabeth Åvall-Lundqvist, et al.Pageof 28